| ID | 68914 |
| FullText URL | |
| Author |
Nishimura, Midori Filiz
Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences
Haratake, Tomoka
Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences
Nishimura, Yoshito
Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
publons
researchmap
Nishikori, Asami
Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences
Sumiyoshi, Remi
The Research Program for Intractable Disease by Ministry of Health, Labor and Welfare, Castleman Disease, TAFRO and Related Ddisease Research Group
Ujiie, Hideki
Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences
Kawahara, Yuri
Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences
Koga, Tomohiro
The Research Program for Intractable Disease by Ministry of Health, Labor and Welfare, Castleman Disease, TAFRO and Related Ddisease Research Group
Ueki, Masao
School of Information and Data Sciences, Nagasaki University
Laczko, Dorottya
Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania
Oksenhendler, Eric
Department of Clinical Immunology, Hôpital Saint-Louis
Fajgenbaum, David C.
Center for Cytokine Storm Treatment and Laboratory, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania
van Rhee, Frits
Myeloma Center, University of Arkansas for Medical Sciences
Kawakami, Atsushi
The Research Program for Intractable Disease by Ministry of Health, Labor and Welfare, Castleman Disease, TAFRO and Related Ddisease Research Group
Sato, Yasuharu
Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences
ORCID
Kaken ID
researchmap
|
| Abstract | Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder classified into three recognized clinical subtypes—idiopathic plasmacytic lymphadenopathy (IPL), TAFRO, and NOS. Although clinical criteria are available for subtyping, diagnostically challenging cases with overlapping histopathological features highlight the need for an improved classification system integrating clinical and histopathological findings. We aimed to develop an objective histopathological subtyping system for iMCD that closely correlates with the clinical subtypes. Excisional lymph node specimens from 94 Japanese iMCD patients (54 IPL, 28 TAFRO, 12 NOS) were analyzed for five key histopathological parameters: germinal center (GC) status, plasmacytosis, vascularity, hemosiderin deposition, and “whirlpool” vessel formation in GC. Using hierarchical clustering, we visualized subgroups and developed a machine learning-based decision tree to differentiate the clinical subtypes and validated it in an external cohort of 12 patients with iMCD. Hierarchical cluster analysis separated the IPL and TAFRO cases into mutually exclusive clusters, whereas the NOS cases were interspersed between them. Decision tree modeling identified plasmacytosis, vascularity, and whirlpool vessel formation as key features distinguishing IPL from TAFRO, achieving 91% and 92% accuracy in the training and test sets, respectively. External validation correctly classified all IPL and TAFRO cases, confirming the reproducibility of the system. Our histopathological classification system closely aligns with the clinical subtypes, offering a more precise approach to iMCD subtyping. It may enhance diagnostic accuracy, guide clinical decision-making for predicting treatment response in challenging cases, and improve patient selection for future research. Further validation of its versatility and clinical utility is required.
|
| Keywords | clinical subtype
histopathological criteria
idiopathic multicentric castleman disease
lymphoproliferative disease
machine-learning
|
| Published Date | 2025-06-20
|
| Publication Title |
American Journal of Hematology
|
| Publisher | Wiley
|
| ISSN | 0361-8609
|
| NCID | AA00520673
|
| Content Type |
Journal Article
|
| language |
English
|
| OAI-PMH Set |
岡山大学
|
| Copyright Holders | © 2025 The Author(s).
|
| File Version | publisher
|
| PubMed ID | |
| DOI | |
| Web of Science KeyUT | |
| Related Url | isVersionOf https://doi.org/10.1002/ajh.27743
|
| License | http://creativecommons.org/licenses/by/4.0/
|
| Citation | M. F. Nishimura, T. Haratake, Y. Nishimura, et al., “ International Consensus Histopathological Criteria for Subtyping Idiopathic Multicentric Castleman Disease Based on Machine Learning Analysis,” American Journal of Hematology (2025): 1–11, https://doi.org/10.1002/ajh.27743.
|
| 助成情報 |
22K15405:
硝子血管型キャッスルマン病における分子遺伝学的特徴の解明と新規診断マーカーの探索
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
23K14476:
Idiopathic plasmacytic lymphadenopathyの病態解明へのアプローチ
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
24KK0172:
日米間における特発性多中心性キャッスルマン病の国際病理基準の確立と患者実態調査
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
25K02476:
特発性多中心性キャッスルマン病:病態解明に向けた分子基盤、病理および臨床の統合
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
23FC1025:
キャッスルマン病、TAFRO症候群、類縁疾患の診療ガイドラインの策定や更なる改良に向けた国際的な総意形成を踏まえた調査研究
( 厚生労働省 / Ministry of Health )
|